INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS. [electronic resource]
Producer: 20170425Description: 47-50 p. digitalISSN:- 1937-1578
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Breast Neoplasms -- pathology
- Fatal Outcome
- Female
- Glaucoma, Angle-Closure -- drug therapy
- Humans
- Intravitreal Injections
- Iris Neoplasms -- drug therapy
- Middle Aged
- Neovascularization, Pathologic -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.